Sensoril's whole design is concentration. By including the withanolide-rich leaf, it standardises to ≥10% withanolides — double KSM-66's ≥5%. That means it works at 125-250 mg/day, the lowest effective dose of any patented ashwagandha. If minimising capsule size and daily milligrams matters to you, Sensoril is built for exactly that.
KSM-66 vs Sensoril
Reviewed
Verified by SAC team
+20
XP on completion
KSM-66 and Sensoril are the two patented ashwagandha extracts that dominate the shelf — and the choice between them is a real fork, not marketing noise. KSM-66 (Ixoreal) is root-ONLY, standardised to ≥5% withanolides, and the most-studied ashwagandha in the world, with the only human data on testosterone and strength (Lopresti 2019, Wankhede 2015). Sensoril (Natreon) is root + LEAF, standardised to ≥10% withanolides — the highest concentration — and works at a lower dose, historically positioned for stress and anxiety. Below: 6 rounds head-to-head, honest scoring, and a verdict that names the one case where Sensoril is the right buy.
Contender A
Sensoril (root + leaf)
Natreon · ≥10% withanolides · 125-250 mg · stress-specialist
The highest-concentration extract — ≥10% withanolides from root + leaf, effective at a lower dose. The concentration-efficient pick when pure stress/anxiety is the only goal.
8.1/10
Best forPure stress / anxiety · smallest effective dose · lowest capsule load
Read the full ranking →
Contender B
KSM-66 (root only)
Ixoreal · ≥5% withanolides · 300-600 mg · most-studied
Root-only, full-spectrum, and the most-studied ashwagandha extract in existence — the only one with human testosterone and strength data. The broad, default pick.
9.0/10
Best forBroad lift · testosterone + strength · long-term daily use
Read the full ranking →
How we scored each round
Six criteria that actually decide a real buy between these two extracts. Each round, both contenders get a 0-10 score based on the published human trials and their standardisation specs. The winner is whoever scores higher; ties are explicit when both are genuinely comparable. We do not credit Sensoril for KSM-66's testosterone data or vice versa.
- Concentration + dose-efficiency15%
Withanolide standardisation and the milligram dose needed for effect.
- Trial-evidence base25%
Number + quality of indexed placebo-controlled RCTs on the branded extract.
- Testosterone + strength20%
Published human data on hormones, strength, and body composition.
- Stress / anxiety / cortisol20%
Magnitude + consistency of stress, anxiety, and cortisol outcomes.
- Purity + long-term profile10%
Plant part used, withaferin A load, suitability for daily long-term use.
- Cost + accessibility10%
Monthly cost at the effective dose + availability of well-QC'd product.
6 rounds — head-to-head on the criteria that matter
- Round 1
Round 1 · Concentration + dose-efficiency
Withanolide standardisation + dose needed for effectSensoril (root + leaf)9.0 KSM-66 (root only)7.5 KSM-66 targets ≥5% withanolides from root only, so the effective dose is higher — 300-600 mg/day across its trials (though a validated 240 mg dose exists for stress). To match Sensoril's withanolide load you'd take roughly double the milligrams. That's a real ergonomic disadvantage on this one axis, even if it doesn't change outcomes.
- Round 2
Round 2 · Trial-evidence base
Indexed placebo-controlled RCTs on the branded extractSensoril (root + leaf)6.5 Sensoril's evidence is real but thinner in the indexed literature. Its most-cited stress trial (Auddy 2008) was published in a journal that isn't MEDLINE-indexed. Indexed root + leaf standardised-aqueous trials do exist — Pingali 2014 (cognition + reaction time) and Pandit 2024 (dose-ranging perceived-stress reduction at 125/250/500 mg) — but they're fewer, smaller, and mostly not carrying the Sensoril brand name on the record.
KSM-66 (root only)9.5 KSM-66 is the most-studied ashwagandha extract in the world — 5+ indexed placebo-controlled RCTs by brand name: Chandrasekhar 2012 (stress/cortisol), Lopresti 2019 ×2 (testosterone; stress/sleep), Wankhede 2015 (strength), and Salve 2019 (anxiety). Multiple populations, replicated cortisol effects, and the only hormone + strength data in the category. The trial base isn't close.
- Round 3
Round 3 · Testosterone + strength
Published human data on hormones, strength, body compositionSensoril (root + leaf)5.5 Honestly: Sensoril has no published human testosterone or strength trial. Its indexed data sits on stress and cognition endpoints. It may or may not move hormones — we simply don't have the trial to say, and it would be dishonest to imply otherwise. If testosterone or strength is any part of your goal, Sensoril is a blank on the exact endpoint you care about.
KSM-66 (root only)9.3 KSM-66 owns this round outright. Lopresti 2019 measured +14.7% testosterone and +18% DHEA-S over the treatment period in overweight stressed men. Wankhede 2015 showed greater strength gains, more lean mass, and a larger testosterone rise (+96 ng/dL vs +18 placebo) alongside reduced exercise-induced muscle damage in trained men. This is the only extract with that data.
- Round 4
Round 4 · Stress / anxiety / cortisol
Magnitude + consistency of stress + cortisol outcomesSensoril (root + leaf)8.6 Stress is Sensoril's home turf. It's positioned and dosed for it — 125-250 mg from a ≥10% extract. The indexed root+leaf data backs the direction: Pandit 2024 showed dose-dependent perceived-stress (PSS) reductions at 125-500 mg, and Pingali 2014 showed cognitive/reaction-time gains consistent with reduced stress load. Its historical stress trial (Auddy 2008, non-indexed) reported cortisol reductions up to ~32%.
KSM-66 (root only)8.8 KSM-66's cortisol data is arguably the best-documented in the whole category: Chandrasekhar 2012 cut serum cortisol −27.9% and perceived stress −44% at 600 mg; Lopresti 2019 dropped morning cortisol −23% at just 240 mg; Salve 2019 showed −14% cortisol plus anxiety-scale improvements. Multiple indexed replications of the same effect.
- Round 5
Round 5 · Purity + long-term profile
Plant part, withaferin A load, daily long-term suitabilitySensoril (root + leaf)7.5 Sensoril's concentration comes from the leaf, which is richest in withaferin A — the single most cytotoxic withanolide in cell studies. At normal doses Sensoril is well-tolerated across its trials, so this isn't an alarm. But for high-dose or indefinite daily use, the higher withaferin A fraction is a legitimate mark against the leaf-inclusive approach.
KSM-66 (root only)8.7 KSM-66 is root-only — the part Ayurveda traditionally used — and deliberately keeps withaferin A low while preserving the full-spectrum root profile. That's the more conservative composition for someone planning to run ashwagandha daily for months. Its multi-month trials show clean tolerability at clinical doses.
- Round 6
Round 6 · Cost + accessibility
Monthly cost at effective dose + product availabilitySensoril (root + leaf)8.3 Sensoril runs about $12-25/month, and its lower effective dose can stretch a bottle further. It's a widely licensed patent with solid Natreon QC, though it appears in fewer finished products than KSM-66 — you'll see it on fewer shelves and in fewer third-party-tested SKUs.
KSM-66 (root only)8.3 KSM-66 runs about $12-30/month and is in far more finished products, including many with public Certificates of Analysis and third-party testing. The higher dose costs slightly more per serving, but the sheer availability and QC transparency of the KSM-66 ecosystem offsets it.
After 6 rounds
1
Sensoril (root + leaf)
2
Ties
3
KSM-66 (root only)
KSM-66 is the default for almost everyone — Sensoril is the pure-stress specialist
After 6 rounds the scoreboard is 3-1 with 2 ties in KSM-66's favour, and that tracks the evidence honestly. KSM-66 has the broadest indexed trial base of any ashwagandha, the only human testosterone and strength data, and the root-only purity that suits long-term daily use. For most buyers, that's the whole decision.
But don't dismiss Sensoril — it wins the round it's built for. At ≥10% withanolides it delivers stress and anxiety relief at 125-250 mg, the smallest effective dose on the shelf. If your ONLY goal is calming a stressed HPA axis and you want the lowest capsule load, Sensoril is the concentration-efficient pick, and the stress round is a genuine tie on outcome quality.
The default buy is KSM-66. 300-600 mg/day with a meal for 8-12 weeks. If testosterone, strength, sleep, or a broad stress-plus-recovery lift is anywhere in your goal, it's the only extract with the data to back it. Choose Sensoril in exactly one situation: pure stress/anxiety, smallest dose, and you don't care about the hormone angle.
The one wrong move: buying Sensoril expecting a testosterone effect. There's no published human T trial on it — that data belongs to KSM-66 (Lopresti 2019, Wankhede 2015). Match the extract to the endpoint, confirm the patent name and a Certificate of Analysis on the label, and rule yourself out first if you have thyroid disease, an autoimmune condition, or are pregnant.
Every claim above traces back to one of these
- [1]Chandrasekhar 2012
A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults
300 mg of KSM-66 twice daily (600 mg/day) for 60 days reduced perceived-stress score by 44% and serum cortisol by 27.9% vs placebo in chronically stressed adults. The cornerstone KSM-66 cortisol-reduction trial.
- [2]Lopresti 2019 (testosterone)
A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males
600 mg/day of KSM-66 raised serum testosterone by 14.7% and DHEA-S by 18% vs placebo in aging, overweight men. The pivotal trial behind KSM-66's testosterone positioning — with no Sensoril equivalent published.
- [3]Lopresti 2019 (stress/sleep)
An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study
240 mg/day of KSM-66 for 60 days reduced morning cortisol by 23% and improved stress and sleep scores vs placebo — demonstrating an effective low-dose KSM-66 stress protocol.
- [4]Wankhede 2015
Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial
600 mg/day of KSM-66 for 8 weeks increased muscle strength and size, raised testosterone (+96 ng/dL vs +18 placebo), and reduced exercise-induced muscle damage in trained men. The strength/hormone trial Sensoril has no counterpart to.
- [5]Salve 2019
Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-Blind, Randomized, Placebo-Controlled Clinical Study
240 mg/day of KSM-66 for 60 days reduced cortisol by roughly 14% and improved Hamilton Anxiety Scale scores vs placebo in healthy adults — replicating the cortisol/anxiety effect at a low dose.
- [6]Pingali 2014
Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants
A standardized root + leaf aqueous Withania somnifera extract (Sensoril-type composition), 500 mg/day for 14 days, improved reaction time, choice discrimination, digit-symbol substitution, and card-sorting vs placebo — supporting the root+leaf extract's cognition/stress profile.
- [7]Pandit 2024
Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial
An 8-week dose-ranging trial of a root + leaf aqueous ashwagandha extract at 125, 250, and 500 mg reduced perceived-stress (PSS) and stress-related biochemical parameters vs placebo — indexed support for the lower-dose root+leaf (Sensoril-type) stress approach.